{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:37:01Z","timestamp":1782232621031,"version":"3.54.5"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s11605-013-2286-2","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T13:33:41Z","timestamp":1374240821000},"page":"1609-1617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer"],"prefix":"10.1016","volume":"17","author":[{"given":"Masanori","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyo","family":"Sakabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsugu","family":"Tanii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichi","family":"Tsujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Koido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigetaka","family":"Shimodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Yonemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Nagaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-013-2286-2_bb0010","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin."},{"key":"10.1007\/s11605-013-2286-2_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1634\/theoncologist.2007-0252","article-title":"Systemic therapy for biliary tract cancers","volume":"13","author":"Hezel","year":"2008","journal-title":"Oncologist."},{"key":"10.1007\/s11605-013-2286-2_bb0020","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"ABC-02 Trial Investigators","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1007\/s11605-013-2286-2_bb0025","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature."},{"key":"10.1007\/s11605-013-2286-2_bb0030","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00008390-200310000-00011","article-title":"Results of a phase I clinical study using autologous tumour lysate-pulsed monocyte-derived mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with low dose interleukin-2","volume":"13","author":"Nagayama","year":"2003","journal-title":"Melanoma Res."},{"key":"10.1007\/s11605-013-2286-2_bb0035","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MPA.0b013e31822398c6","article-title":"Clinical and immunologic evaluation of dendritic cell-based immunotherapy in combination with gemcitabine and\/or S-1 in patients with advanced pancreatic carcinoma","volume":"41","author":"Kimura","year":"2012","journal-title":"Pancreas."},{"key":"10.1007\/s11605-013-2286-2_bb0040","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer","volume":"363","author":"IMPACT Study Investigators","year":"2010","journal-title":"N Engl J Med."},{"key":"10.1007\/s11605-013-2286-2_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/thy.2006.0178","article-title":"Results of a phase I clinical study using dendritic cell vaccinations for thyroid cancer","volume":"17","author":"Kuwabara","year":"2007","journal-title":"Thyroid."},{"key":"10.1007\/s11605-013-2286-2_bb0050","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin Cancer Res."},{"key":"10.1007\/s11605-013-2286-2_bb0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/modpathol.3800588","article-title":"Immunohistochemical detection of WT1 protein in a variety of cancer cells","volume":"19","author":"Nakatsuka","year":"2006","journal-title":"Mod Pathol."},{"key":"10.1007\/s11605-013-2286-2_bb0060","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ejso.2005.03.008","article-title":"MUC 1 core protein as a marker of gallbladder malignancy","volume":"31","author":"Ghosh","year":"2005","journal-title":"Eur J Surg Oncol."},{"key":"10.1007\/s11605-013-2286-2_bb0065","first-page":"649","article-title":"Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact","volume":"22","author":"Park","year":"2009","journal-title":"Oncol Rep."},{"key":"10.1007\/s11605-013-2286-2_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1309\/9R6673QEC06D86Y4","article-title":"Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study","volume":"122","author":"Lau","year":"2004","journal-title":"Am J Clin Pathol."},{"key":"10.1007\/s11605-013-2286-2_bb0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.prp.2010.03.006","article-title":"Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas","volume":"206","author":"Fan","year":"2010","journal-title":"Pathol Res Pract."},{"key":"10.1007\/s11605-013-2286-2_bb0080","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cncr.10398","article-title":"Correlation between expression of MUC1 core protein and outcome after surgery in mass-forming intrahepatic cholangiocarcinoma","volume":"94","author":"Matsumura","year":"2002","journal-title":"Cancer."},{"key":"10.1007\/s11605-013-2286-2_bb0085","first-page":"1001","article-title":"Prognostic nutritional index in gastro-intestinal surgery of malnourished cancer patients","volume":"85","author":"Onodera","year":"1984","journal-title":"Nihon Geka Gakkai Zasshi."},{"key":"10.1007\/s11605-013-2286-2_bb0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3892\/etm.2010.175","article-title":"Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer","volume":"2","author":"Toiyama","year":"2011","journal-title":"Exp Ther Med."},{"key":"10.1007\/s11605-013-2286-2_bb0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-005-0095-3","article-title":"Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancer","volume":"57","author":"Okusaka","year":"2006","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1007\/s11605-013-2286-2_bb0100","first-page":"955","article-title":"A phase I\/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors","volume":"6","author":"Lepisto","year":"2008","journal-title":"Cancer Ther."},{"key":"10.1007\/s11605-013-2286-2_bb0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00534-011-0437-y","article-title":"Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma","volume":"19","author":"Shimizu","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"10.1007\/s11605-013-2286-2_bb0110","first-page":"163","article-title":"Dendritic cell-based immunotherapy","volume":"276","author":"Berger","year":"2003","journal-title":"Curr Top Microbiol Immunol."},{"key":"10.1007\/s11605-013-2286-2_bb0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1081\/CNV-120025091","article-title":"The first 1000 dendritic cell vaccinees","volume":"21","author":"Ridgway","year":"2003","journal-title":"Cancer Invest."},{"key":"10.1007\/s11605-013-2286-2_bb0120","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/jnci\/djq310","article-title":"Improved Endpoints for Cancer Immunotherapy Trials","volume":"102","author":"Hoos","year":"2010","journal-title":"J Natl Cancer Inst."},{"key":"10.1007\/s11605-013-2286-2_bb0125","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1073\/pnas.0712237105","article-title":"Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients","volume":"105","author":"Hodi","year":"2008","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1007\/s11605-013-2286-2_bb0130","first-page":"163","article-title":"Serum albumin: a prognostic indicator in patients with colorectal cancer","volume":"43","author":"Heys","year":"1998","journal-title":"J R Coll Surg Edinb."},{"key":"10.1007\/s11605-013-2286-2_bb0135","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10120-011-0032-6","article-title":"Prognostic factor analysis of third-line chemotherapy in patients with advanced gastric cancer","volume":"14","author":"Shim","year":"2011","journal-title":"Gastric Cancer."},{"key":"10.1007\/s11605-013-2286-2_bb0140","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anchir.2006.03.006","article-title":"Prognostic factors after surgical resection for hilar cholangiocarcinoma","volume":"131","author":"Ramacciato","year":"2006","journal-title":"Ann Chir."},{"key":"10.1007\/s11605-013-2286-2_bb0145","first-page":"662","article-title":"Prognostic factor in gallbladder cancer","volume":"57","author":"Medina-Franco","year":"2005","journal-title":"Rev Invest Clin."},{"key":"10.1007\/s11605-013-2286-2_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1620\/tjem.224.215","article-title":"The nutritional index \u2018COUNT\u2019 is useful for predicting long-term prognosis of patients with end-stage liver disease","volume":"224","author":"Fukushima","year":"2011","journal-title":"Tohoku J Exp Med."},{"key":"10.1007\/s11605-013-2286-2_bb0155","first-page":"231","article-title":"Significance of Onodera's prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy","volume":"39","author":"Okada","year":"2012","journal-title":"Gan To Kagaku Ryoho."},{"key":"10.1007\/s11605-013-2286-2_bb0160","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3346\/jkms.2012.27.11.1354","article-title":"Onodera's Prognostic Nutritional Index as a Risk Factor for Mortality in Peritoneal Dialysis Patients","volume":"27","author":"Kang","year":"2012","journal-title":"J Korean Med Sci."},{"key":"10.1007\/s11605-013-2286-2_bb0165","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br J Cancer."},{"key":"10.1007\/s11605-013-2286-2_bb0170","doi-asserted-by":"crossref","unstructured":"Luo Y, Dorf ME. Delayed-type hypersensitivity. Curr Protoc Immunol. 2001; Chapter 4: Unit 4.5.pp1-5.","DOI":"10.1002\/0471142735.im0405s55"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-013-2286-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-013-2286-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23041434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23041434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-013-2286-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:41:12Z","timestamp":1761075672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23041434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1091255X23041434"],"URL":"https:\/\/doi.org\/10.1007\/s11605-013-2286-2","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-013-2286-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}